Cocrystal Pharma
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$17,984,000 over the previous period. Total operating expenses were $22,547,000.

Profit Margin

Cocrystal Pharma, Inc. (NASDAQ:COCP): Profit margin
2014 9K -99K -1100%
2015 78K -50.12M -64258.97%
2016 0 -74.87M
2017 0 -613K
2018 0 -49.04M
2019 6.56M -48.18M -734.13%
2020 2.01M -9.65M -479.44%
2021 0 -14.18M
2022 0 -38.84M
2023 0 -17.98M

COCP Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
0002.01M6.56M00078K9K
Cost of revenue
15.16M241.6K239.5K238.9K4.00K50K101K201K192K4.07K
Gross profit
-15.16M-241.6K-239.5K1.77M6.55M-50K-101K-201K-114K4.92K
Operating exp.
Research and development
15.16M12.39M8.79M6.30M4.00M58.57M5.82M101.67M47.26M4.07M
Selling and marketing
0000000000
Total operating expenses
22.54M18.13M14.22M11.6M8.86M62.92M8.26M105.81M54.02M5.80M
Operating income
-18.55M-38.82M-14.22M-9.58M-48.40M-62.92M-8.26M-105.81M-53.94M-5.79M
Other income (expenses), net
575K-8K36K-62K237K352K769K1.42M-11.42M5.64M
Income before tax
-17.98M-38.83M-14.18M-9.64M-48.16M-62.63M-7.49M-104.26M-65.37M-151K
Income tax expense
08K4K8K19K-13.58M-6.88M-29.39M-15.24M-52K
Net income
-17.98M-38.84M-14.18M-9.65M-48.18M-49.04M-613K-74.87M-50.12M-99K
Earnings per share
Basic EPS
-0.00-4.77-0.16-0.17-1.51-21.01-0.3-38.17-28.6-0.29
Diluted EPS
-0.00-4.77-0.16-0.17-1.51-21.01-0.3-38.14-28.6-0.29
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source